An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Endeavor Health Clinical Trials Center, Glenview, Illinois

Bernstein Clinical Research Center, LLC, Cincinnati, Ohio

Germany

Institute of Allergology IFA Charité - Campus Benjamin Franklin | Hindenburgdamm 30, Berlin